BILLS-117hr941rfs.pdf

23:30 Apr 19 2005 each of fiscal years 2022 42 U.S.C. 274k(d)(2 April 15, 2021 each of fiscal years 2016 fiscal year 2015 8 later than 2 years 2015 each calendar year 2 years APRIL 19, 2021 20 June 30, 2025 2026 each of fiscal years 2021

the ‘‘Timely ReAuthoriza- SESSION H. R. 941

PO 00000 Frm 00004 PO 00000 Frm 00005 PO 00000 Frm 00006 PO 00000 Frm 00007 PO 00000 Frm 00003 Fmt PO 00000 Frm 00001 PO 00000 Frm 00002

the United States the United States of America

the Stem Cell Therapeutic and Research Act

APPROPRIATIONS.—To

Senate the Public Health Service Act Labor the Committee on Health, Education SEC Program Energy and Commerce the House of Representatives Committee U.S.C. Institutes of Health ADVISORY COUNCIL the Stem Cell Therapeutic and Research Reauthor- the National Institutes of Health the Advisory Council Advisory CONGRESS National House of Representa- Drug Administration Food and Drugs GAO Programs Lends Access NIH the Comptroller General the Health Resources and Services Administration House THE FIELD OF REGENERATIVE

CHERYL L. JOHNSON

regenerative stem cell therapies bills rfs rfs cells advisory council pensions section public health education medicine institutes service act blood